HCA Healthcare-backed Sarah Cannon Research Institute, an operator of a cancer research center, agreed to merge with McKesson-backed US Oncology Research, a provider of medical oncology services, cancer center services, and cancer research services. Financial terms were not disclosed. “McKesson and HCA Healthcare share a commitment to advancing the next generation of cancer care. This new joint venture is an important step forward in increasing access to clinical trials, particularly within the community setting, where the majority of all cancer patients are initially treated. Additionally, the joint venture directly aligns with McKesson’s strategic growth priorities by further expanding our differentiated oncology ecosystem and improving the value proposition for provider and biopharma partners," Brian Tyler, McKesson CEO.